182 related articles for article (PubMed ID: 36119042)
1. Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia.
Michelis R; Milhem L; Galouk E; Stemer G; Aviv A; Tadmor T; Shehadeh M; Shvidel L; Barhoum M; Braester A
Front Immunol; 2022; 13():953644. PubMed ID: 36119042
[TBL] [Abstract][Full Text] [Related]
2. The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia.
Naseraldeen N; Michelis R; Barhoum M; Chezar J; Tadmor T; Aviv A; Shvidel L; Litmanovich A; Shehadeh M; Stemer G; Shaoul E; Braester A
Front Immunol; 2020; 11():603569. PubMed ID: 33643290
[TBL] [Abstract][Full Text] [Related]
3. A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.
Michelis R; Tadmor T; Barhoum M; Shehadeh M; Shvidel L; Aviv A; Stemer G; Dally N; Rahimi-Levene N; Yuklea M; Braester A
PLoS One; 2019; 14(1):e0209024. PubMed ID: 30601845
[TBL] [Abstract][Full Text] [Related]
4. Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway.
Michelis R; Tadmor T; Aviv A; Stemer G; Majdob R; Shvidel L; Shehadeh M; Barhoum M; Braester A
PLoS One; 2020; 15(3):e0230033. PubMed ID: 32150580
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
6. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
7. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
8. Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia.
Baig NA; Taylor RP; Lindorfer MA; Church AK; LaPlant BR; Pettinger AM; Shanafelt TD; Nowakowski GS; Zent CS
J Immunol; 2014 Feb; 192(4):1620-9. PubMed ID: 24431228
[TBL] [Abstract][Full Text] [Related]
9. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
10. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
11. Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type.
Rossi JF; Commes T; Grenier J; Jourdan M; Chichehian B; Klein B
Am J Hematol; 1988 Dec; 29(4):183-8. PubMed ID: 3142255
[TBL] [Abstract][Full Text] [Related]
12. Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion.
Tempescul A; Bagacean C; Riou C; Bendaoud B; Hillion S; Debant M; Buors C; Berthou C; Renaudineau Y
Eur J Haematol; 2016 Mar; 96(3):229-35. PubMed ID: 25911969
[TBL] [Abstract][Full Text] [Related]
13. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
[TBL] [Abstract][Full Text] [Related]
14. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans.
Martinez-Torres AC; Quiney C; Attout T; Boullet H; Herbi L; Vela L; Barbier S; Chateau D; Chapiro E; Nguyen-Khac F; Davi F; Le Garff-Tavernier M; Moumné R; Sarfati M; Karoyan P; Merle-Béral H; Launay P; Susin SA
PLoS Med; 2015 Mar; 12(3):e1001796. PubMed ID: 25734483
[TBL] [Abstract][Full Text] [Related]
15. Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.
Blanco G; Puiggros A; Sherry B; Nonell L; Calvo X; Puigdecanet E; Chiu PY; Kieso Y; Ferrer G; Palacios F; Arnal M; Rodríguez-Rivera M; Gimeno E; Abella E; Rai KR; Abrisqueta P; Bosch F; Calon A; Ferrer A; Chiorazzi N; Espinet B
Exp Hematol; 2021 Mar; 95():68-80. PubMed ID: 33421548
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Chronic Lymphocytic Leukemia With Recurrent Complement-Mediated Thrombotic Microangiopathy and C3 Glomerulonephritis.
Ma T; Wang H; Su T; Wang S
Front Med (Lausanne); 2022; 9():813439. PubMed ID: 35223908
[TBL] [Abstract][Full Text] [Related]
17. Defective complement activity in chronic lymphocytic leukemia.
Heath ME; Cheson BD
Am J Hematol; 1985 May; 19(1):63-73. PubMed ID: 3845763
[TBL] [Abstract][Full Text] [Related]
18. CD45RO+ T-cells immunoregulate spontaneous in vitro immunoglobulin production by normal and chronic lymphocytic leukaemia B-cells.
Frolova EA; Scott SC; Jones RA
Leuk Lymphoma; 1995 Jun; 18(1-2):103-11. PubMed ID: 8580811
[TBL] [Abstract][Full Text] [Related]
19. Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL).
Marquart HV; Grønbaek K; Christensen BE; Svehag SE; Leslie RG
Clin Exp Immunol; 1995 Dec; 102(3):575-81. PubMed ID: 8536375
[TBL] [Abstract][Full Text] [Related]
20. CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.
Pulte D; Furman RR; Broekman MJ; Drosopoulos JH; Ballard HS; Olson KE; Kizer JR; Marcus AJ
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):367-72. PubMed ID: 21816376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
